Picture of EQL Pharma AB logo

EQL — EQL Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapNeutral

Brief: EQL Pharma Q2 Net Sales At SEK 157.2 Mln

BRIEF-EQL Pharma Q2 Net Sales At SEK 157.2 Mln

- EQL Pharma AB EQL.ST:

  • Q2 NET SALES AMOUNT TO SEK 157.2 MILLION, GROWTH OF 82%

  • Q2 EBITDA MARGIN RECOVERS TO 19%

  • SALES FORECAST FOR FULL YEAR 2026/27 IS GROWTH OF AROUND 15%

  • WE EXPECT FOUR ADDITIONAL LAUNCHES DURING FINANCIAL YEAR, BUT FORECAST IS UNCERTAIN

Source text: ID:nWkr6WNc64

Further company coverage: EQL.ST


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on EQL Pharma AB

See all news